Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
<i>Pseudomonas aeruginosa</i> is a pathogen often encountered in a healthcare setting. It has consistently ranked among the most frequent pathogens seen in nosocomial infections, particularly bloodstream and respiratory tract infections. Aside from having intrinsic resistance to many ant...
Saved in:
Main Authors: | Johnny Zakhour (Author), Sima L. Sharara (Author), Joya-Rita Hindy (Author), Sara F. Haddad (Author), Souha S. Kanj (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What is Currently Known About the SARS-CoV2 Variants of Concern
by: Tarek Souaid, et al.
Published: (2021) -
Cervical osteomyelitis potentially caused by Campylobacter fetus
by: Bassem Awada, et al.
Published: (2021) -
Antimicrobial susceptibility of <i>Pseudomonas aeruginosa</i> isolated from wound infections
by: Anupurba Shampa, et al.
Published: (2006) -
<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021) -
Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022)